Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment
Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 compl...
Saved in:
Published in | Nature communications Vol. 16; no. 1; pp. 3144 - 16 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
02.04.2025
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
ISSN | 2041-1723 2041-1723 |
DOI | 10.1038/s41467-025-58350-z |
Cover
Abstract | Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.
LSD1-CoREST-HDAC1/2 complexes are degraded by both the drug UM171 and cancer-associated mutations in the E3 ligase KBTBD4. Here, the authors use cryo-EM to demonstrate how these mutations and UM171 similarly alter KBTBD4 to recruit HDAC1/2, illustrating a natural example of a molecular glue. |
---|---|
AbstractList | Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies. Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies. Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies.LSD1-CoREST-HDAC1/2 complexes are degraded by both the drug UM171 and cancer-associated mutations in the E3 ligase KBTBD4. Here, the authors use cryo-EM to demonstrate how these mutations and UM171 similarly alter KBTBD4 to recruit HDAC1/2, illustrating a natural example of a molecular glue. Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies. LSD1-CoREST-HDAC1/2 complexes are degraded by both the drug UM171 and cancer-associated mutations in the E3 ligase KBTBD4. Here, the authors use cryo-EM to demonstrate how these mutations and UM171 similarly alter KBTBD4 to recruit HDAC1/2, illustrating a natural example of a molecular glue. Abstract Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations in the Kelch domain of the KBTBD4 E3 ligase rewire epigenetic programs for stemness in medulloblastoma by recruiting LSD1-CoREST-HDAC1/2 complexes as neo-substrates for ubiquitination and degradation. UM171, an investigational drug for haematopoietic stem cell transplantation, was found to degrade LSD1-CoREST-HDAC1/2 complexes in a wild-type KBTBD4-dependent manner, suggesting a potential common mode of action. Here, we identify that these neomorphic interactions are mediated by the HDAC deacetylase domain. Cryo-EM studies of both wild-type and mutant KBTBD4 capture 2:1 and 2:2 KBTBD4-HDAC2 complexes, as well as a 2:1:1 KBTBD4-HDAC2-CoREST1 complex, at resolutions spanning 2.7 to 3.3 Å. The mutant and drug-induced complexes adopt similar structural assemblies requiring both Kelch domains in the KBTBD4 dimer for each HDAC2 interaction. UM171 is identified as a bona fide molecular glue binding across the ternary interface. Most strikingly, the indel mutation reshapes the same surface of KBTBD4 providing an example of a natural mimic of a molecular glue. Together, the structures provide mechanistic understanding of neomorphic KBTBD4, while structure-activity relationship (SAR) analysis of UM171 reveals analog S234984 as a more potent molecular glue for future studies. |
ArticleNumber | 3144 |
Author | Chen, Xiangrong Szabo, Timea Chen, Zhuoyao Montes, Beatriz Ralsi Chi, Gamma Kiss, Arpad D’Angiolella, Vincenzo Herner, András Clifford, Steven C. Novak, Tibor Kotschy, András Balo, Timea Bullock, Alex N. |
Author_xml | – sequence: 1 givenname: Zhuoyao orcidid: 0000-0003-4201-4649 surname: Chen fullname: Chen, Zhuoyao organization: Centre for Medicines Discovery, University of Oxford – sequence: 2 givenname: Gamma orcidid: 0000-0001-9910-0965 surname: Chi fullname: Chi, Gamma organization: Centre for Medicines Discovery, University of Oxford – sequence: 3 givenname: Timea orcidid: 0009-0009-4013-8243 surname: Balo fullname: Balo, Timea organization: Servier Research Institute of Medicinal Chemistry, Hevesy György Ph.D. School of Chemistry, Eötvös Loránd University – sequence: 4 givenname: Xiangrong orcidid: 0000-0003-0587-3444 surname: Chen fullname: Chen, Xiangrong organization: Centre for Medicines Discovery, University of Oxford – sequence: 5 givenname: Beatriz Ralsi surname: Montes fullname: Montes, Beatriz Ralsi organization: Centre for Medicines Discovery, University of Oxford – sequence: 6 givenname: Steven C. orcidid: 0000-0003-4893-2184 surname: Clifford fullname: Clifford, Steven C. organization: Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer – sequence: 7 givenname: Vincenzo orcidid: 0000-0001-8365-9094 surname: D’Angiolella fullname: D’Angiolella, Vincenzo organization: The Institute of Genetics and Cancer, University of Edinburgh, Crewe Road South – sequence: 8 givenname: Timea orcidid: 0000-0003-0700-4680 surname: Szabo fullname: Szabo, Timea organization: Servier Research Institute of Medicinal Chemistry – sequence: 9 givenname: Arpad surname: Kiss fullname: Kiss, Arpad organization: Servier Research Institute of Medicinal Chemistry – sequence: 10 givenname: Tibor surname: Novak fullname: Novak, Tibor organization: Servier Research Institute of Medicinal Chemistry – sequence: 11 givenname: András orcidid: 0009-0005-1406-3971 surname: Herner fullname: Herner, András organization: Servier Research Institute of Medicinal Chemistry – sequence: 12 givenname: András surname: Kotschy fullname: Kotschy, András organization: Servier Research Institute of Medicinal Chemistry – sequence: 13 givenname: Alex N. orcidid: 0000-0001-6757-0436 surname: Bullock fullname: Bullock, Alex N. email: alex.bullock@cmd.ox.ac.uk organization: Centre for Medicines Discovery, University of Oxford |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40175372$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1v1DAUtFARLUv_AAdkiQuXUH88x_EJtdtCK4o40J4tx7G3XiXxYidI7a_H3S2l5YAvz7Jnxs_z5jXaG-PoEHpLyUdKeHOUgUItK8JEJRouSHX3Ah0wArSikvG9J_t9dJjzmpTFFW0AXqF9IFQKLtkBWv-Y0mynOZkeD2EINt3i6PH1NyopNmOHRxeHmDY3wWJrRusSHubJjFPGNlZxU-oZx31Ymezw15Ork1PAPiZ8fnq8pEcMJ2fTHKbBjdMb9NKbPrvDh7pA15_Prpbn1eX3LxfL48vKgoKpahvBSdtJR30HRijWgiUAHsAqwTrvKAMQrW8VY9Q4abmpQUjTWG65B8UX6GKn20Wz1psUBpNudTRBbw9iWmmTpmB7pxVzTlKQbc0UtNwYqlrjlW89I03dyaL1aae1mdvBdbZ8ozj1TPT5zRhu9Cr-0pSqWhSbi8KHB4UUf84uT3oI2bq-N8XZOWtOGyGbWpZ5LND7f6DrOKexeLVFCcIUuUe9e9rSYy9_ZloAbAewKeacnH-EUKLvs6N32dElO3qbHX1XSHxHygU8rlz6-_Z_WL8BLZ3E9Q |
Cites_doi | 10.1016/j.celrep.2020.01.091 10.1016/j.molcel.2013.05.020 10.1182/bloodadvances.2023010599 10.1016/j.sbi.2011.08.004 10.1038/s41580-024-00729-9 10.1016/j.cell.2022.04.014 10.1107/S0907444904019158 10.1016/S2352-3026(19)30202-9 10.1002/iub.504 10.1016/j.sbi.2019.01.004 10.1093/nar/gkaa1121 10.1038/s41598-018-32927-9 10.1016/j.jbc.2023.104662 10.1016/j.freeradbiomed.2015.05.034 10.1038/s44320-024-00055-4 10.1016/j.molcel.2006.01.013 10.1038/s41467-022-28507-1 10.1074/jbc.M112.437996 10.1016/j.str.2019.06.005 10.1007/s11060-023-04310-w 10.21037/sci-2023-016 10.1038/nature13527 10.1016/j.molcel.2006.07.012 10.1016/j.chembiol.2024.05.004 10.1074/jbc.M113.490706 10.1016/j.chembiol.2021.04.009 10.7554/eLife.59994 10.1021/acs.biochem.6b01014 10.1038/s41586-024-08533-3 10.1107/S2059798319011471 10.1038/s41467-024-48045-2 10.1038/s41589-023-01409-z 10.1126/science.aal3755 10.1038/s41418-022-00983-4 10.1002/jcc.20084 10.1007/s00401-019-01990-5 10.1038/s41419-024-06565-1 10.1126/science.1256337 10.1093/jmcb/mjy021 10.1098/rsob.200041 10.1038/s41594-020-0405-9 10.1073/pnas.95.21.12123 10.1038/s41467-021-23609-8 10.1016/j.stem.2020.12.002 10.1038/nature22973 10.1042/BJ20140153 10.1038/onc.2016.312 10.1016/j.molcel.2009.09.022 10.1021/jm701079h 10.1016/j.cell.2008.07.022 10.1038/nature08617 10.1038/s41594-023-01182-6 10.1038/sj.emboj.7601243 10.1038/s41586-020-2374-x 10.1016/j.str.2023.09.002 10.1038/s41586-024-08532-4 10.1182/blood.2020005827 10.1038/s41586-021-03819-2 10.1126/science.aat0572 |
ContentType | Journal Article |
Copyright | The Author(s) 2025 2025. The Author(s). Copyright Nature Publishing Group 2025 The Author(s) 2025 2025 |
Copyright_xml | – notice: The Author(s) 2025 – notice: 2025. The Author(s). – notice: Copyright Nature Publishing Group 2025 – notice: The Author(s) 2025 2025 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-025-58350-z |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Health Research Premium Collection ProQuest Central Essentials Biological Science Collection (subscription) ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 16 |
ExternalDocumentID | oai_doaj_org_article_92ee7147b6294b3aa19baf9fbf2086d7 PMC11965401 40175372 10_1038_s41467_025_58350_z |
Genre | Journal Article |
GrantInformation_xml | – fundername: Cancer Research UK (CRUK) grantid: DRCNPG-May21\100002 funderid: https://doi.org/10.13039/501100000289 – fundername: Gedeon Richter funderid: https://doi.org/10.13039/501100003358 – fundername: Innovative Medicines Initiative (IMI) grantid: 875510 funderid: https://doi.org/10.13039/501100010767 – fundername: Cancer Research UK (CRUK) grantid: DRCNPG-May21\100002 – fundername: Innovative Medicines Initiative (IMI) grantid: 875510 – fundername: Wellcome Trust |
GroupedDBID | --- 0R~ 39C 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ AASML ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ADBBV ADFRT ADMLS ADRAZ AENEX AEUYN AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LGEZI LK8 LOTEE M1P M7P M~E NADUK NAO NXXTH O9- OK1 P2P P62 PHGZT PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP AAYXX CITATION PHGZM CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. M48 P64 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS RC3 SOI 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c494t-b8530bd7e1fd4a592b4c044f44c952dfe12445bfb9221ae7c3a6457a8c3c3f493 |
IEDL.DBID | C6C |
ISSN | 2041-1723 |
IngestDate | Wed Aug 27 01:24:50 EDT 2025 Thu Aug 21 18:38:42 EDT 2025 Fri Sep 05 17:45:29 EDT 2025 Sat Aug 23 12:31:10 EDT 2025 Sat May 17 01:30:13 EDT 2025 Tue Jul 01 05:11:58 EDT 2025 Thu Apr 03 03:05:22 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2025. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c494t-b8530bd7e1fd4a592b4c044f44c952dfe12445bfb9221ae7c3a6457a8c3c3f493 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-9910-0965 0000-0003-4893-2184 0000-0003-4201-4649 0009-0009-4013-8243 0000-0001-6757-0436 0009-0005-1406-3971 0000-0003-0700-4680 0000-0001-8365-9094 0000-0003-0587-3444 |
OpenAccessLink | https://www.nature.com/articles/s41467-025-58350-z |
PMID | 40175372 |
PQID | 3185502905 |
PQPubID | 546298 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_92ee7147b6294b3aa19baf9fbf2086d7 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11965401 proquest_miscellaneous_3185786775 proquest_journals_3185502905 pubmed_primary_40175372 crossref_primary_10_1038_s41467_025_58350_z springer_journals_10_1038_s41467_025_58350_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-04-02 |
PublicationDateYYYYMMDD | 2025-04-02 |
PublicationDate_xml | – month: 04 year: 2025 text: 2025-04-02 day: 02 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2025 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | KF Ahmad (58350_CR31) 1998; 95 SC Lo (58350_CR40) 2006; 25 K Zemaitis (58350_CR24) 2023; 299 Z Kozicka (58350_CR50) 2021; 28 S Cohen (58350_CR21) 2020; 7 B Padmanabhan (58350_CR39) 2006; 21 ME Matyskiela (58350_CR9) 2020; 27 I Fares (58350_CR19) 2014; 345 S Cao (58350_CR48) 2022; 13 J Chagraoui (58350_CR23) 2021; 28 Y Deng (58350_CR54) 2024; 15 V Takiar (58350_CR2) 2017; 36 RDW Kelly (58350_CR42) 2018; 8 SL Schreiber (58350_CR5) 2024; 31 P Canning (58350_CR30) 2013; 288 D Liebschner (58350_CR59) 2019; 75 CJ Millard (58350_CR29) 2013; 51 EF Pettersen (58350_CR57) 2004; 25 J Jumper (58350_CR56) 2021; 596 P Emsley (58350_CR58) 2004; 60 S Bastani (58350_CR18) 2023; 10 JC Lee (58350_CR16) 2019; 137 M Slabicki (58350_CR12) 2020; 585 M Yang (58350_CR26) 2006; 23 W Wang (58350_CR34) 2024; 15 X Mo (58350_CR3) 2022; 185 PA Northcott (58350_CR15) 2017; 547 OM Moradei (58350_CR46) 2007; 50 A Subramaniam (58350_CR22) 2020; 136 BE Lauffer (58350_CR47) 2013; 288 Z Chen (58350_CR37) 2020; 10 CJ Jeffery (58350_CR1) 2011; 63 S Yamashita (58350_CR17) 2023; 162 CJ Millard (58350_CR51) 2020; 48 P Canning (58350_CR35) 2015; 88 ES Fischer (58350_CR8) 2014; 512 M Zhuang (58350_CR27) 2009; 36 NJ Porter (58350_CR45) 2019; 59 S Cohen (58350_CR20) 2023; 7 Z Chen (58350_CR36) 2019; 27 L Dang (58350_CR7) 2009; 462 Y Yang (58350_CR28) 2018; 10 Z Chen (58350_CR14) 2022; 29 Z Kozicka (58350_CR49) 2024; 20 Y Song (58350_CR25) 2020; 30 DM Duda (58350_CR55) 2008; 134 58350_CR13 FR Schumacher (58350_CR38) 2014; 460 Y Hu (58350_CR32) 2024; 31 58350_CR53 58350_CR52 58350_CR11 58350_CR10 P Hosseinzadeh (58350_CR43) 2021; 12 NJ Porter (58350_CR44) 2016; 55 58350_CR4 PM Lombardi (58350_CR41) 2011; 21 58350_CR6 F Teng (58350_CR33) 2023; 31 |
References_xml | – volume: 30 start-page: 2699 year: 2020 ident: 58350_CR25 publication-title: Cell Rep. doi: 10.1016/j.celrep.2020.01.091 – volume: 51 start-page: 57 year: 2013 ident: 58350_CR29 publication-title: Mol. Cell doi: 10.1016/j.molcel.2013.05.020 – volume: 7 start-page: 5717 year: 2023 ident: 58350_CR20 publication-title: Blood Adv. doi: 10.1182/bloodadvances.2023010599 – volume: 21 start-page: 735 year: 2011 ident: 58350_CR41 publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/j.sbi.2011.08.004 – ident: 58350_CR6 doi: 10.1038/s41580-024-00729-9 – volume: 185 start-page: 1974 year: 2022 ident: 58350_CR3 publication-title: Cell doi: 10.1016/j.cell.2022.04.014 – volume: 60 start-page: 2126 year: 2004 ident: 58350_CR58 publication-title: Acta Crystallogr D. Biol. Crystallogr doi: 10.1107/S0907444904019158 – volume: 7 start-page: e134 year: 2020 ident: 58350_CR21 publication-title: Lancet Haematol. doi: 10.1016/S2352-3026(19)30202-9 – volume: 63 start-page: 489 year: 2011 ident: 58350_CR1 publication-title: IUBMB Life doi: 10.1002/iub.504 – volume: 59 start-page: 9 year: 2019 ident: 58350_CR45 publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/j.sbi.2019.01.004 – volume: 48 start-page: 12972 year: 2020 ident: 58350_CR51 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa1121 – volume: 8 year: 2018 ident: 58350_CR42 publication-title: Sci. Rep. doi: 10.1038/s41598-018-32927-9 – volume: 299 start-page: 104662 year: 2023 ident: 58350_CR24 publication-title: J. Biol. Chem. doi: 10.1016/j.jbc.2023.104662 – volume: 88 start-page: 101 year: 2015 ident: 58350_CR35 publication-title: Free Radic. Biol. Med doi: 10.1016/j.freeradbiomed.2015.05.034 – ident: 58350_CR4 doi: 10.1038/s44320-024-00055-4 – volume: 21 start-page: 689 year: 2006 ident: 58350_CR39 publication-title: Mol. Cell doi: 10.1016/j.molcel.2006.01.013 – volume: 13 year: 2022 ident: 58350_CR48 publication-title: Nat. Commun. doi: 10.1038/s41467-022-28507-1 – volume: 288 start-page: 7803 year: 2013 ident: 58350_CR30 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.437996 – volume: 27 start-page: 1395 year: 2019 ident: 58350_CR36 publication-title: Structure doi: 10.1016/j.str.2019.06.005 – volume: 162 start-page: 425 year: 2023 ident: 58350_CR17 publication-title: J. Neurooncol doi: 10.1007/s11060-023-04310-w – volume: 10 start-page: 15 year: 2023 ident: 58350_CR18 publication-title: Stem Cell Investig. doi: 10.21037/sci-2023-016 – volume: 512 start-page: 49 year: 2014 ident: 58350_CR8 publication-title: Nature doi: 10.1038/nature13527 – volume: 23 start-page: 377 year: 2006 ident: 58350_CR26 publication-title: Mol. Cell doi: 10.1016/j.molcel.2006.07.012 – volume: 31 start-page: 1050 year: 2024 ident: 58350_CR5 publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2024.05.004 – volume: 288 start-page: 26926 year: 2013 ident: 58350_CR47 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.490706 – volume: 28 start-page: 1032 year: 2021 ident: 58350_CR50 publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2021.04.009 – ident: 58350_CR13 doi: 10.7554/eLife.59994 – volume: 55 start-page: 6718 year: 2016 ident: 58350_CR44 publication-title: Biochemistry doi: 10.1021/acs.biochem.6b01014 – ident: 58350_CR53 doi: 10.1038/s41586-024-08533-3 – volume: 75 start-page: 861 year: 2019 ident: 58350_CR59 publication-title: Acta Crystallogr D. Struct. Biol. doi: 10.1107/S2059798319011471 – volume: 15 year: 2024 ident: 58350_CR34 publication-title: Nat. Commun. doi: 10.1038/s41467-024-48045-2 – volume: 20 start-page: 93 year: 2024 ident: 58350_CR49 publication-title: Nat. Chem. Biol. doi: 10.1038/s41589-023-01409-z – ident: 58350_CR11 doi: 10.1126/science.aal3755 – volume: 29 start-page: 1955 year: 2022 ident: 58350_CR14 publication-title: Cell Death Differ. doi: 10.1038/s41418-022-00983-4 – volume: 25 start-page: 1605 year: 2004 ident: 58350_CR57 publication-title: J. Comput Chem. doi: 10.1002/jcc.20084 – volume: 137 start-page: 851 year: 2019 ident: 58350_CR16 publication-title: Acta Neuropathol. doi: 10.1007/s00401-019-01990-5 – volume: 15 year: 2024 ident: 58350_CR54 publication-title: Cell Death Dis. doi: 10.1038/s41419-024-06565-1 – volume: 345 start-page: 1509 year: 2014 ident: 58350_CR19 publication-title: Science doi: 10.1126/science.1256337 – volume: 10 start-page: 285 year: 2018 ident: 58350_CR28 publication-title: J. Mol. Cell Biol. doi: 10.1093/jmcb/mjy021 – volume: 10 start-page: 200041 year: 2020 ident: 58350_CR37 publication-title: Open Biol. doi: 10.1098/rsob.200041 – volume: 27 start-page: 319 year: 2020 ident: 58350_CR9 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/s41594-020-0405-9 – volume: 95 start-page: 12123 year: 1998 ident: 58350_CR31 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.95.21.12123 – volume: 12 year: 2021 ident: 58350_CR43 publication-title: Nat. Commun. doi: 10.1038/s41467-021-23609-8 – volume: 28 start-page: 48 year: 2021 ident: 58350_CR23 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2020.12.002 – volume: 547 start-page: 311 year: 2017 ident: 58350_CR15 publication-title: Nature doi: 10.1038/nature22973 – volume: 460 start-page: 237 year: 2014 ident: 58350_CR38 publication-title: Biochem J. doi: 10.1042/BJ20140153 – volume: 36 start-page: 1607 year: 2017 ident: 58350_CR2 publication-title: Oncogene doi: 10.1038/onc.2016.312 – volume: 36 start-page: 39 year: 2009 ident: 58350_CR27 publication-title: Mol. Cell doi: 10.1016/j.molcel.2009.09.022 – volume: 50 start-page: 5543 year: 2007 ident: 58350_CR46 publication-title: J. Med Chem. doi: 10.1021/jm701079h – volume: 134 start-page: 995 year: 2008 ident: 58350_CR55 publication-title: Cell doi: 10.1016/j.cell.2008.07.022 – volume: 462 start-page: 739 year: 2009 ident: 58350_CR7 publication-title: Nature doi: 10.1038/nature08617 – volume: 31 start-page: 336 year: 2024 ident: 58350_CR32 publication-title: Nat. Struct. Mol. Biol. doi: 10.1038/s41594-023-01182-6 – volume: 25 start-page: 3605 year: 2006 ident: 58350_CR40 publication-title: EMBO J. doi: 10.1038/sj.emboj.7601243 – volume: 585 start-page: 293 year: 2020 ident: 58350_CR12 publication-title: Nature doi: 10.1038/s41586-020-2374-x – volume: 31 start-page: 1431 year: 2023 ident: 58350_CR33 publication-title: Structure doi: 10.1016/j.str.2023.09.002 – ident: 58350_CR52 doi: 10.1038/s41586-024-08532-4 – volume: 136 start-page: 2151 year: 2020 ident: 58350_CR22 publication-title: Blood doi: 10.1182/blood.2020005827 – volume: 596 start-page: 583 year: 2021 ident: 58350_CR56 publication-title: Nature doi: 10.1038/s41586-021-03819-2 – ident: 58350_CR10 doi: 10.1126/science.aat0572 |
SSID | ssj0000391844 |
Score | 2.4720614 |
Snippet | Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel mutations... Abstract Neomorphic mutations and drugs can elicit unanticipated effects that require mechanistic understanding to inform clinical practice. Recurrent indel... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 3144 |
SubjectTerms | 101/28 13/1 13/106 13/109 13/44 14/1 631/45/474/2073 631/45/535/1258/1259 631/67/395 631/80/304 631/92/613 82/16 82/29 82/58 82/80 9/10 Cancer Co-Repressor Proteins - genetics Co-Repressor Proteins - metabolism Cryoelectron Microscopy Epigenetics HDAC2 protein Hematopoietic stem cells Histone deacetylase Histone Deacetylase 1 - chemistry Histone Deacetylase 1 - genetics Histone Deacetylase 1 - metabolism Histone Deacetylase 2 - chemistry Histone Deacetylase 2 - genetics Histone Deacetylase 2 - metabolism Humanities and Social Sciences Humans Immunosuppressive agents Medulloblastoma Mimicry Mode of action multidisciplinary Mutants Mutation Protein Binding Science Science (multidisciplinary) Stem cell transplantation Stem cells Ubiquitin-protein ligase Ubiquitin-Protein Ligases - chemistry Ubiquitin-Protein Ligases - genetics Ubiquitin-Protein Ligases - metabolism Ubiquitination |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOil9F23SVGht9asLY0s65jNg6UlvTQLuQlJllqXrh12s4fk12cke7fZPuilJ4M9hmHeg0bfEPLOYc7yVUDjNYLnUDeAcTC4vEJ6ZjE_q7Ql4uxzNZvDxwtxcWfVV5wJG-CBB8FNFPNeliBtxRRYbkyprAkq2MCwGm_SPfJCFXeaqRSDucLWBcZbMgWvJytIMSFubxVYdRT5zU4mSoD9f6oyfx-W_OXENCWi00fk4VhB0sOB88fknu-ekPvDTsnrp-T7l4QIG9E06KJdtG55TftA52elLKnpGtr5ftGjdFtHXVT5ki7WcZXwiro-7y_xecLpj_Yrpjf6aXo-PQaKhS2dHR8elRNGMUIu122aTX9G5qcn50ezfFyokDtQcJVbzM2FbaQvQwNGKFSGKwACgFOCNcHHZC9ssIqx0njpuKlASFM77ngAxZ-Tva7v_EtCPXo6Z8Y1FTNgAVvymjceIoSTc5I1GXm_Ea6-HHAzdDrv5rUeVKFRFTqpQt9kZBrlv6WMmNfpBVqCHi1B_8sSMrK_0Z4eHXGl4-VwUTBViIy83X5GF4rnIgYlvh5oZMT1Q5oXg7K3nGD7iQ2dZBmpd8xgh9XdL137LcF0lxGsEf_PyIeNxfzk6--yePU_ZPGaPGDR1OOIEdsne2h5_gCrpyv7JjnKLemIFRc priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgCIkL4puMgYzEDaIm9kscn9C6D1WgcWGVerNsx96CaNK162H763l20k7l6xQpdiTnfT_7-fcI-WDRZ7nSo_DqgqdQ1YB20Nu0xPnMoH-WsUvE2bdyMoUvs2I2bLithrLKjU2MhrrubNgjH4VbvkXGZFZ8XlyloWtUOF0dWmjcJw9yjERC6wYxE9s9loB-XgEMd2UyXo1WEC1D6OFaYOyRpbc7_ijC9v8t1vyzZPK3c9Pojk6fkMdDHEkPe8Y_Jfdc-4w87DtL3jwnP75HXNiAqUHnzbyxyxvaeTo9y0VOdVvT1nXzDmncWGoD45d0vg4NhVfUdmm3wOcJpz-bC3Ry9Ov4fHwMFMNbOjk-PMpHjKKdXK6bWKH-gkxPT86PJunQViG1IOE6NeihM1MLl_sadCGRJTYD8ABWFqz2Lrj8wngjGcu1E5brEgqhK8st9yD5S7LXdq17TahDfedM27pkGgxgYl7x2kEAcrJWsDohHzfEVYsePUPFU29eqZ4VClmhIivUbULGgf7bmQH5Or7olhdqUCQlmXMiB2FKJsFwrXNptJfeeIbZWS0ScrDhnhrUcaXuhCch77fDqEjhdEQjxdf9HBHQ_XDOq57Z25VgEoppnWAJqXbEYGepuyNtcxnBuvMA2YjfJ-TTRmLu1vVvWuz__zfekEcsCHEoIWIHZA9lyr3F6OjavIsq8AvNRAv_ priority: 102 providerName: ProQuest |
Title | Structural mimicry of UM171 and neomorphic cancer mutants co-opts E3 ligase KBTBD4 for HDAC1/2 recruitment |
URI | https://link.springer.com/article/10.1038/s41467-025-58350-z https://www.ncbi.nlm.nih.gov/pubmed/40175372 https://www.proquest.com/docview/3185502905 https://www.proquest.com/docview/3185786775 https://pubmed.ncbi.nlm.nih.gov/PMC11965401 https://doaj.org/article/92ee7147b6294b3aa19baf9fbf2086d7 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swEBf9YLCXse9564IGe9tMbelsWY9JmixktIy1gb4ZSZZaj8UuSfPQ_vU7yUlGtu5hLxZYJxD3oTtJp98R8tGgz7K5Q-VVGY-hqADXQWfiHOmZRv8sQ5WI07N8MoPpZXa5R9jmLUxI2g-QlmGZ3mSHHS8hmLQvvpph0JDE9_vksBA881o9zIfbcxWPeF4ArN_HJLx4YOiODwpQ_Q_Fl3-nSf5xVxpc0PgpebKOHWm_m-0zsmeb5-RRV03y7gX5cR6wYD2OBp3X89os7mjr6Ow0FSlVTUUb285b5GttqPHCXtD5yhcRXlLTxu0NtiNOf9ZX6Njo18HF4AQohrR0ctIfpseM4tq4WNUhK_0lmY1HF8NJvC6lEBuQcBtr9MqJroRNXQUqkygGkwA4ACMzVjnr3XymnZaMpcoKw1UOmVCF4YY7kPwVOWjaxr4h1KKNc6ZMlTMFGnAzXvDKggdvMkawKiKfNswtbzrEjDLcdPOi7ERRoijKIIryPiIDz_8tpUe7Dj_axVW5ln4pmbUiBaFzJkFzpVKplZNOO4Y7skpE5GgjvXJtgsvSPwvPEiaTLCIftt1oPP5GRCHHVx2N8Ih-SPO6E_Z2JrjxxK2cYBEpdtRgZ6q7PU19HQC6Uw_TiOMj8nmjMb_n9W9evP0_8nfkMfNK7dOI2BE5QB2z7zFCutU9si8uBX6L8ZceOez3p-dTbAejs2_fe8FceuHs4RcSIBBR |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTQheEHcCA4wETxA1cZzbw4TWtVNH1wpBK-3N-DqCaFLaVaj7cfw2jp2kU7m97SlS7EjOOcfn4sv3IfRKQszSiQHj5XHk00xR8ING-gn0JwLic-5YIkbjZDCl78_isx30s70LY49Vtj7ROWpVSbtG3rG3fOOA5EH8bv7dt6xRdne1pdDgDbWCOnAQY83FjqFe_4ASbnlw0gN9vybkuD85GvgNy4AvaU4vfAEBKxAq1aFRlMc5jFAGlBpKZR4TZbSNgLEwIick5DqVEU9onPJMRjIy1IIxQQjYo3YBZRftdfvjDx83qzwWfz2jtLmtE0RZZ0mdb7IssjFkP4F_uRURHXHA37LdPw9t_rZz6wLi8R10u8lk8WFtenfRji7voRs1t-X6Pvr6ySHTWlQPPCtmhVyscWXwdBSmIealwqWuZhVouZBYWtNb4NnKUhovsaz8ag7PfoS_FecQZvGwO-n2KIYEGw96h0dhh2Dw1ItV4c7IP0DTaxH5Q7RbVqV-jLAGjxMRLlVCOBVUC6i4laYWSkrKlCgPvWmFy-Y1fgdz--5RxmpVMFAFc6pglx7qWvlvelrsbfeiWpyzZiqznGidhjQVCcmpiDgPc8FNboQhUB-q1EP7rfZY4xCW7Mp8PfRy0wxT2e7PcJD4qu6TWnxB6POoVvZmJFAGQ2GZEg9lW2awNdTtlrL44uDCQwsaCd976G1rMVfj-rcsnvz_N16gm4PJ6JSdnoyHT9EtYg3aHmgi-2gX7Es_g1ztQjxvJgRGn697Dv4CGGtPnw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamTSBeEHcCYzMSPEHUxHHi5GFC69qqo6yaYJX2FnwdQTQp7SrU_UR-FcdO0qnc3vZUqXEl99xPfPx9CL2SkLN0YsB4eRz5NFUU4qCRfgLriYD8nDmWiJNxMpzQ9-fx-Rb62d6FsWOVbUx0gVpV0r4j79hbvnFAsiDumGYs4rQ3eDf77lsGKXvS2tJp8IZmQR04uLHmksdIr35AO7c4OO6B7l8TMuifHQ39hnHAlzSjl76A5BUIxXRoFOVxBruVAaWGUpnFRBlts2EsjMgICblmMuIJjRlPZSQjQy0wE6SDHQZZHxrBnW5_fPpx_cbHYrGnlDY3d4Io7Syoi1OWUTaGSijwrzayoyMR-Fvl--cA52-nuC45Du6hu01Viw9rM7yPtnT5AN2qeS5XD9HXTw6l1iJ84GkxLeR8hSuDJychCzEvFS51Na1A44XE0prhHE-Xlt54gWXlVzP47Ef4W3EBKRePumfdHsVQbONh7_Ao7BAMUXu-LNy8_CM0uRGRP0bbZVXqpwhriD4R4VIlhFNBtYDuW2lqYaWkZER56E0r3HxWY3nk7gw-SvNaFTmoIneqyK881LXyX6-0ONzui2p-kTdunWdEaxZSJhKSURFxHmaCm8wIQ6BXVMxDu6328iY4LPJrU_bQy_VjcGt7VsNB4st6DbNYg7DmSa3s9U6gJYYmkxEPpRtmsLHVzSdl8cVBh4cWQBJ-76G3rcVc7-vfsnj2_7-xj26DL-Yfjsej5-gOsfZsZ5vILtoG89IvoGy7FHuNP2D0-aZd8BcBwlPj |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structural+mimicry+of+UM171+and+neomorphic+cancer+mutants+co-opts+E3+ligase+KBTBD4+for+HDAC1%2F2+recruitment&rft.jtitle=Nature+communications&rft.au=Chen%2C+Zhuoyao&rft.au=Chi%2C+Gamma&rft.au=Balo%2C+Timea&rft.au=Chen%2C+Xiangrong&rft.date=2025-04-02&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2041-1723&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-025-58350-z&rft.externalDocID=10_1038_s41467_025_58350_z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |